Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
Boni, V Garcia-Corbacho, J Ott, PA Cho, DC Autio, KA Uboha, N Spira, AI Humphrey, R Will, M Naing, A
Boni, V
Garcia-Corbacho, J
Ott, PA
Cho, DC
Autio, KA
Uboha, N
Spira, AI
Humphrey, R
Will, M
Naing, A
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Boni V, Garcia-Corbacho J, Ott PA, Cho DC, Autio KA, Uboha N, et al. 435P Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors. Annals of Oncology. 2018;29(suppl_8).